Analysis of self-reported versus biomarker based smoking prevalence: methodology to compute corrected smoking prevalence rates-Reference-Cited by-同舟云学术

Analysis of self-reported versus biomarker based smoking prevalence: methodology to compute corrected smoking prevalence rates

Published:2017-01-17 Issue:5 Volume:22 Page:476-487
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Jain Ram B.¹

Affiliation:

1. Private Consultant, Dacula, GA, USA

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2016.1278264

Reference18 articles.

1. Adhikari, B. et al. 2008. Smoking-attributable mortality, years of potential life lost, and productivity losses – United State, 2000–2004. MMWR, 57, 1226–1228.

2. Assessing secondhand smoke using biological markers

3. The burden of smoking-related ill health in the UK

4. Slower Metabolism and Reduced Intake of Nicotine From Cigarette Smoking in Chinese-Americans

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolución de la prevalencia de consumo de tabaco en España y sus 17 comunidades autónomas (1987-2020);Medicina Clínica;2024-01

2. The effect of smoking on clinical and biochemical early healing outcomes of coronally advanced flap with connective tissue graft: Prospective cohort study;Journal of Periodontology;2023-07-19

3. Associations between exposure to brominated flame retardants and metabolic syndrome and its components in U.S. adults;Science of The Total Environment;2023-02

4. Smoking-attributable mortality in the autonomous communities of Spain, 2017;Revista Española de Cardiología (English Edition);2022-02

5. Mortalidad atribuida al consumo de tabaco en las comunidades autónomas de España, 2017;Revista Española de Cardiología;2022-02